{
    "Trade/Device Name(s)": [
        "HemosIL Fibrinogen-C"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K073367",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931721"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KQJ"
    ],
    "Summary Letter Date": "December 27, 2007",
    "Summary Letter Received Date": "November 30, 2007",
    "Submission Date": "November 29, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.7340"
    ],
    "Regulation Name(s)": [
        "Fibrinogen Determination System"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL TOP"
    ],
    "Method(s)/Technology(ies)": [
        "Clauss method"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Fibrinogen-C assay for quantitative determination of fibrinogen in human citrated plasma using the Clauss method on IL Coagulation Systems",
    "Indications for Use Summary": "Intended for the quantitative determination of fibrinogen, based on the Clauss method, in human citrated plasma on IL Coagulation Systems for in vitro diagnostic use",
    "fda_folder": "Hematology"
}